Acorda Therapeutics has announced the appointment of Peter S. Carbone as Senior VP, Quality. Carbone was most recently VP of Quality Solids Americas & Special Technologies at Novartis and previously held executive positions at Amgen and Allergan.
Carbone commented, “I am very excited to be joining Acorda. The approval of Inbrija is an important milestone for the Company and for patients, and I look forward to partnering with the company’s quality teams to maintain and build on the excellent systems they have developed.”
Acorda President and CEO Ron Cohen said, “Peter brings to Acorda over 30 years of pharmaceutical and industry experience in engineering, quality and technical management. We are delighted to welcome him to our leadership team. One of our top priorities is to continue to the build upon the strong track record of success of our quality teams as we manufacture and commercialize Inbrija and develop other products in our pipeline. Peter’s leadership will be critical to these efforts.”
Read the Acorda Therapeutics press release.
